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ABSTRACT 
Aflatoxins (AFBi) are contaminants easily found in prolonged storage of 
foods and feeds. Aflatoxins can cause illness and death. AFBi requires 
biotransformation to form highly reactive epoxide intermediates by cytochrome P450 
enzymes. These activated metabolites bind irreversibly to DNA promoting the 
formation oftumor. Several synthetic drugs were reported to exert protection against 
AFBi intoxication. The target organ of aflatoxins is the liver. Naturally occurring 
phytochemicals that possess hepatoprotective ability are worth studying. 
Licorice plants are widely used in food industry and are popular ingredients 
found in snacks. The major component of licorice plants is glycyrrhizic acid (GA). It 
is commonly used as anti-hepatitis drug in Japan. GA shows high effectiveness in 
restoring many liver functions after liver injuries. Treatment of cells with GA was 
tested to see if i t could minimize the toxic effects of AFBi. Ascorbic acid (AA), a 
well known antioxidant, and licorice extract (EX) were also used. 
It is no doubt that AFBi is toxic. Human normal endothelial cell line 
(ECV304) and mice fibroblast (L929) were found more sensitive to AFBi 
intoxication. Human hepatoma cell line (HepG2) was less susceptible to the toxicity 
of AFBi. It was safe to take GA at low concentration. This was also observed in cells. 
However, severe cell death was monitored when incubating cells with large amount 
ofEX. L929 and ECV304 were very sensitive to GA and EX comparing with HepG2. 
ii 
Abstract 
GA and EX protected cells from AFBi intoxication. GA showed greater 
protection ofcells than EX did. Cells were incubated with different amounts ofdrugs 
for different periods of time. The protective effects of GA and EX varied with the 
exposure period of time. It was independent of the exposure concentration. The 
revival of cell viability was highest in HepG2 among the cell lines studied. The 
chemoprotection was found least significant in ECV304. 
In addition, in order to study the protective properties of GA and EX, their 
effects on enzymes involved in the metabolism of AFBi were studied. The effects of 
GA and EX on P450 and GST were examined. The GST assay was carried out in 
both rat microsomes and crude fractions from cells. The P450 assay was tested on the 
rat microsomes only. The activity of GST and P450 was activated by GA and 
suppressed by EX in all samples. The activity was more vigorous when the 
concentration of GA and EX increased. Moreover, the effects of GA and EX were 
enhanced according to the incubation periods. 
To conclude, GA and EX protected cells from AFBi intoxication. The 
protection mechanism was not clear from this study. However, the protective effects 
might be due to the interactions of all the major components in the licorice plants 
with the enzymes involved. The effect of a single component showed relative weak 
protective properties. 
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ABBREVIATIONS 
AA Ascorbic Acid 
AFBi AflatoxinBi 
AFBi-dihydrodiol 8,9-dihydro-8,9-dihydroxy-aflatoxinBi 
AFBi-epoxide Aflatoxin Bi-8,9-epoxide 
AFBi-GSH Aflatoxin Brglutathione complex 
AFB2 Aflatoxin B2 
AFB2a Aflatoxin B2a 
AFGi Aflatoxin Gi 
AFG2 Aflatoxin G2 
AFL Aflatoxicol 
AFMi Aflatoxin Mi 
AFPi Aflatoxin Pi 
AFQi Aflatoxin Qi 
BHA Butylated hydroxyanisole 
BHT Butylated hydroxytoluene 




ECV304 Human umbilical cord endothelial cell 
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ELISA Enzyme linked immuno-sorbent assay 
ER 7-Ethoxyresorufin 
EROD 7-Ethoxyresorufin 0-Dealkylase assay 
EX Licorice Extract 
FCS Fetal Calf Serum 
GA Glycyrrhizic Acid 
GSH Glutathione 
GST Glutathione-S-Transferase 
HepG2 Human hepatoma cell line 
L929 Mice fibroblast 
MR Methoxyresorufin 
MROD Methoxyresorufin 0-Dealkylase assay 
MTT Methylthiazol tetrazolium 
NADPH Nicotinamide Adenine Dinucleotide Phosphate 
NOEL No observed effect level 
撒 Neutral Red 
PBS Phosphate buffer saline 
RPMI 1640 Roswell Park Memorial Institute tissue culture medium 1640 
RR Resorufin 
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Chapter One INTRODUCTION 
1.1 AFLATOXmS 
It was a singular event that occurred in 1960 in Britain that established the 
significance of mycotoxicosis at the international level. This was the death of 
thousands of turkey poultry, ducklings and chicks, and later became known as “ 
Turkey-X" disease. Several compounds that fluoresced under ultraviolet illumination 
were analyzed. These compounds were named aflatoxins (McLean, M., and Dutton, 
M.F., 1995). 
Aflatoxin is a kind of mycotoxin, which is a secondary metabolite produced 
under hot and humid conditions by fungi in foods and feeds. The toxins can cause 
illness or death OEaton, Dl.，and Gallagher, E.P., 1994). There are two ways human 
may expose to aflatoxins: intake of contaminated foods directly, through animals fed 
with contaminated crops or the consumption of food produced by these animals (Lau, 
G.S.N.，1997). The diseases caused by these mycotoxins are mycotoxicoses and 
generally are classified according to the symptoms resulting from ingestion (McLean, 
M., and Dutton, M.F., 1995). It is now clear that aflatoxins are the only members of 
this group that can cause cancer. There is sufficient evidence of hepatocarcinogenesis 
by aflatoxin in man. 
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Aflatoxin is produced by Aspergillus flavus (^-/a-toxin) (Denning, D.W.， 
1987) and Aspergillus parasiticus. Aflatoxins can be produced under different 
growing conditions during pre-harvest time and prolong storage of foods and feeds. 
There are four major members of aflatoxins. They are aflatoxin Bi (AFBi), B2 
(AFB2), Gi (AFGi) and G2 (AFG2). Their structures are shown in Figure 1.1 
(McLean, M.，and Dutton, M.F., 1995). 
AFBi and AFB2 are the major metabolites only produced by Aspergillus 
flavus, while AFGi and AFG2 are mainly produced by Aspergillus parasiticus. These 
aflatoxins are distinguished by the color of their fluorescence under long-wave 
ultraviolet illumination. AFBi and AFB2 illuminate blue fluorescence and aflatoxin 
AFGi and AFG2 illuminate green fluorescence (B 二 blue; G = green). Amongst these 
four members, AFBi is the most toxic and exists the highest concentration in nature. 
The order ofacute and chronic toxicity is AFBi > AFGi > AFB2 > AFG2, reflecting 
the role played by the saturation of 8,9-double bond and the expoxidation to form 
toxic metabolites (McLean, M.，and Dutton, M.F., 1995 and Lau, G.S.N., 1997). 
It is known that aflatoxins are very stable in dry heat environment until the 
temperature raises to its melting point. Due to their heat stable property, they are not 
destroyed under cooking conditions (McLean, M.，and Dutton, M.F., 1995). The 
chemical and physical properties are shown in Table 1.1 (Lau, G.S.N., 1997). 
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Table 1.1 Chemical and physical properties of aflatoxins 
Aflatoxins Molecular Formula~~Molecular Weight~~Melting Point (^C) 
Ara^ C17H12O6 ‘ ^ ^ 
AFB2 C17H14O6 314 286 
AFGi C17H12O7 328 244 
AFG2 C17H14O7 330 237 
“ (Lau, G.S.N., 1997) 
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Figure 1.1 Structure of aflatoxins 
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1.1.1 AFB1 METABOLISM 
Although aflatoxin is non-toxic itself，it is metabolized to produce an ultimate 
carcinogenic metabolites, e.g. aflatoxin epoxide (AFBi-8,9-epxoide). AFBi is 
actively metabolized by different mechanisms in different animal species. The 
relative importance of each pathway is dependent on the animal species as well as the 
experimental conditions. Metabolites are recovered from urine, milk and various in 
vitro incubation systems containing liver slices, homogenates or sub-cellular fractions 
(Eaton, D.L. and Gallagher, E.P.，1994 and Lau, G.S.N., 1997). 
. The initial metabolism of AFBi essentially involves hydration, hydroxylation, 
demethylation and oxidation by the cytochrome P450 microsomal mixed-function 
oxidase system and a cytosolic nicotinamide adenine dinucleotide phosphate 
ON[ADPH)-dependent reductase. Different enzyme systems yield different 
metabolites. Only some of them are removed by phase II biotransformation (Lau, 
G.S.N., 1997). 
1.1.2 BlOACTWATION 
The biotransformation of relatively inert chemicals to highly reactive 
metabolites is commonly referred to as "metabolic activation" or “bioactivation，，. The 
major metabolites o fAFBi are shown in Figure 1.2 (Lau, G.S.N.，1997). Those 
formed by demethylation or hydroxylation of APBi are comparatively less toxic and 
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could be removed by phase II biotransformation. Others are relatively more toxic as 
they could not be removed by other enzyme systems. They are the products of 
bioactivation from AFBi from different enzyme systems. 
Aflatoxicol (AFL) is formed through the catalytic reaction by NADPH-
reductase. This reversible reaction may result in prolongation of AFBi toxicity in our 
bodies. Therefore it might act as a sink or reservoir of AFBi. Aflatoxin B2a (AFB2a) is 
formed by the oxidation of AFBi at the 8,9 unsaturated carbon (Eaton, D1 . , and 
Gallagher, E.P., 1994). It is responsible for the acute aflatoxin toxicity and the 
formation ofprotein adducts (McLean, M., and Dutton, M.F., 1995). 
AFBi-8,9-epoxide (AFBi-epoxide) resulted through epoxidation. It is the 
ultimate carcinogen in the aflatoxin metabolism. Epoxide binds irreversibly to 
nucleophilic groups, DNA, RNA and protein to form adducts. If the damage involves 
uncontrollable cell proliferation, cancer will result. Therefore, epoxide is a potent 
mutagen, carcinogen and tetratogen (Denning, D.W.，1987). 
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AFBi is metabolized by P450 to less reactive metabolites through 
hydroxylation and demethylation (Eaton, D.L., and Gallagher, E.P., 1994). The 
products are aflatoxin Mi (AFMi), Pi (AFPi) and Qi (AFQi). These metabolites are 
poor substrates for epoxidation or, after epoxidation，do not interact with DNA 
(Guengerich, F.P. et al., 1998). They are removed by phase II conjugation and 
excreted in the urine and milk (McLean, M.，and Dutton, M.F., 1995). 
On the other hand, the major detoxification reaction of AFBi is the 
conjugation of reactive epoxide to glutathione complex (McLean, M.，and Dutton, 
MJF., 1995). The only detoxification pathway, other than possible macromolecular 
binding not involving a toxic response, is by conjugation with glutathione to form 
AFBi-glutathione complex (AFBi-GSH). The AFBi-GSH is excreted primarily 
through the bile. This reaction is catalyzed by glutathione S-transferase (GST). 
Though GST comprises a large family of enzymes which are divided into 5 classes, 
little is known about the GST which are responsible for the detoxification of activated 
AFBi (Lau, G.S.N.，1997). 
AFBi-epoxide might also be detoxified by other phase II enzymes like UDP-
glucuronyl-transferase (UGT) and sulphotransferase, but these reactions are not 
significant in detoxifying AFBi-epoxide (McLean, M.，and Dutton, M.F., 1995). A 
very minor pathway may involve the spontaneous or epoxide hydrolase-catalysed 
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1.2 LlCORICE PLANTS 
Licorice plant is an ancient herb that has been used for medicinal purpose for 
centuries. About two-thirds of all Chinese herbal formulas include licorice. The 
commercially available licorice plants are Glycyrrhiza glabra, uralensis, echinate and 
inflata. They are the members of the legume family. 
Licorice plants are found only in areas with specific environmental conditions. 
During their growing cycle, licorice plants undergo a stress cycle caused by lack of 
moisture and temperature variations. During this time，secondary metabolites are 
produced. One of the commercially available metabolites produced is glycyrrhizic 
acid (GA). After they are harvested, the roots of licorice plants are air-dried before 
they are sold in the market. Due to its pharmacological activity, flavoring and 
chemical characteristics, GA is one of the most important constituents from licorice 
plant. Traditionally, the content o fGA (about 1-5%) is used to determine the cost and 
quality ofthe licorice product (Vora, P.S., and Testa, L.C.A., 1997). Table 1.2 shows 




reaction of the epoxide with water, producing 8,9-dihydro-8,9-dihydroxy-AFBi 
(AFBi dihydrodiol). This reaction is probably not catalysed by epoxide hydrolase as 
the induction ofthis enzyme in rats by pretreatment with antioxidants did not result in 
corresponding decreased DNA-binding (Lau, G.S.N., 1997 and Guengerich, F.P. et 
aL, 1998). 
The detoxification process of aflatoxin epoxide remains unclear. 
1.1.4 TOXICITY OF AFB1 
AFBi is basically non-toxic itself. However, metabolic activation of AFBi 
yields toxic metabolites AFBi-epoxide. Their ability to form protein adduct，mainly 
serum albumin and plasma protein, adduct formation affects the protein synthesis 
which results in an alternation of serum protein concentrations and leads to 
suppression of immunity. Epoxide binds irreversibly to nucleophilic groups to form 
AFBi-DNA adduct (Lau, G.S.N.，1997). Its structure is shown in Figure 1.3. Thus, 
the adduct may play a role in the development of extrahepatic cancers. Previous 
studies reported that there was a good correlation between high levels of aflatoxin in 
the diet and liver cancer. Therefore, aflatoxin epoxide is an ultimate carcinogen in the 
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Table 1.2 Composition of licorice root 
Content % 
= = = > = = _ = _ = = _ = « « = — = = « = = = = = > = = = — — — = = = = = = = 
Dietary insoluble fiber 50-60 
Water soluble solids 26-38 
Carbohydrates 18-22 
Inorganic salts 6-10 
Glycyrrhizic aicd 1-5 
‘ (Vora, P.S., and Testa, L.C.A., 1997) 
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1 2 . 1 GLYCYRRfflZIC ACID ( G A ) 
Glycyrrhizic acid (GA), other name glycyrrhizin from Merck index, is a 
natural constituent of licorice isolated from the dried root of Glycyrrhizica glabra. 
GA is a triterpene molecule with an aglycone associated with the two moieties of 
glucuronic acid (Vora, P.S., and Testa, L.C.A.，1997). The structure is shown in 
Figure 1.4. 
GA is used in a wide variety of products. Most of the licorice supply is used 
by the tobacco industry and others shared by the food and pharmaceutical industries 
(Stomer, F.C., Reistad, R.，and Alexander, J., 1993). Salts of GA are widely used as 
sweeteners and aromatizers in sweets, drugs and beverages. It is approximately 50 
times sweeter than sucrose and has a synergistic effect with other sweeteners (Vora, 
P.S., and Testa, L.C.A., 1997). Certain "health products" such as licorice-flavoured 
diet gum, licorice tea and throat pearls may contain much higher levels of GA. An 
investigation from New Zealand on licorice intake among high school students 
showed that licorice was eaten regularly by 29% of the girls and 17% of the boys 
(Stomer, F.C., Reistad, R., and Alexander, J., 1993). 
This compound is well known for its anti-inflammartry property (Kobayashi, 
S. etal., 1995). Also GA and the derivatives show anti-allergic, anti-viral, anti-tumor 
(Yi, H., Nakashima, I., and Isobe, K.I., 1995) and anti-ulcerous effects. Moreover, it 
is used as radioprotector and found effective on promoting recovery from radiation 
damage (Lin, I.H. etal., 1996). 
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Previous studies have reported that GA is an effective hepatoprotective agent 
and the administration of high dose of GA is effective for improvement of liver 
function (Shiota, G , Harada K. I , and Ishida，M., 1999). Also, GA has significant 
restorative and protective effects on GST activity and glutathione content in the liver 
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Figure 1.4 Structure of Glycyrrhizic Acid (GA) 
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1 .2.2 METABOLISM OF G A 
A small but significant amount o fGA is absorbed in the intact form from the 
gastrointestinal tract (Yamamura, Y. et al., 1992), while a significant portion of the 
absorbed GA is excreted in bile before reaching the systemic circulation. Unabsorbed 
GA is metabolized to glycyrrhetic acid done by gastrointestinal tract glycyrrhizin-
hydrolysing bacteria, especially anaerobic bacteria located in large intestine 
(Gunnarslottir, S.，and Johannesson，T., 1997). The structure of glycyrrhetic acid is 
shown in Figure 1.5. Most of glycyrrhetic acid is absorbed from the large intestine 
and is believed to show the hepatoprotective ability during circulation (Wang, Z. et 
al., 1995 and Wang, Z. et al.，1996). A previous study reported that no glycyrrhetic 
acid had been detected in human plasma after intravenous administration of GA and 
more than 80% of intravenously given GA was recovered in the unchanged form in 
bile. This indicated that no biotransformation of GA to glycyrrhetic acid inthe liver 
(Takeda, S. etal, 1996 and Wang, Z. etal, 1996). 
The GA bacterial hydrolyzing enzyme is localized in the stomach, duodenal, 
upper small intestinal, lower small intestinal, cecal and colonic contents. The 
contents of these glycyrrhizic-hydrolysing bacteria in stomach possess weak 
hydrolyzing activity, where the activity is highest in cecum and colon. The highest 
metabolic rate is measured at pH 8, however, the intestinal contents of pH 6 or pH 7 
30 
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are able to metabolize GA (Akao, T., 1997). This indicates that the hydrolysis 
reaction is difficult to be carried out in acidic environment. 
Previous reports suggested that when GA is orally ingested in therapy or as a 
sweetener. Glycyrrhetic acid, the major metabolite of GA, played an important role in 
its pharmacological action and its side effects. When GA is given intravenously, GA 
itself dominates in exerting of all biochemical and biological effects (Takeda, S. et 
aL, 1996 and Gunnarsdottir S.，and Johannesson, T.，1997). 
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1.2.3 ADVERSE EFFECTS OF G A 
It is safe to consume GA. The adverse effects of GA are reported only at an 
extremely excess consumption. The following adverse effects are possibly to be 
found at a high intake of GA. Hypermineralocorticoidism is characterized by sodium 
retention, potassium loss and a number of changes in other biochemical and hormonal 
activities (Stormer, F.C., Reistad，R. and Alexander, J., 1993). The hormones of the 
adrenal cortex are increased by GA and resulting in an increased in sodium appetite 
and thirst. Its effects on water intake are likely to be the action of GA on the kidney. 
It causes potassium loss and cellular dehydration. The alternation of salts in blood by 
GA, namely sodium and potassium, leads to an increase in blood pressure (Cooney, 
A.S. and Fitzsimons, J.T., 1996). 
Due to the above side effects, patients of high blood pressure, diabetes and 
heart disease are not recommended to take large amount of licorice-supplemented 
food or GA-containing substances. 
1.3 AlM OF RESEARCH 
In my research, liver cells were used as model for the study of effects of GA 
on AFBi intoxicaiton. The consumption of AFBi-contaminated food is possible. The 
toxic effects of AFBi on human were described in previous studies (Denning, D.W., 
1987). It is important to identify chemicals that would protect human from AFBi 
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intoxication. Since the target organ of AFBi is the liver, new hepatoprotective 
chemicals for the liver will improve its functions. 
Diet is known to affect the general enzyme level in animals. Licorice plants 
are widely used in food industries. The consumption of GA is a daily practice of 
many people. Moreover, glycyrrhizic acid, the major component of licorice, is shown 
to exert certain hepatoprotective ability and is used as an effective medicine for 
hepatitis in Japan for years. Thus, licorice plant and GA are intensively examined in 
their protection against AFBi intoxication to cells. The mechanism is also an 
interesting accept for studying. 
34 
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. Materials and Methods 
Chapter Two MATERIALS AND METHODS 
2.1 CELL CULTURES 
2.1.1 ISOLATION OF SPLENOCYTES 
Splenocytes ofWistar rats were isolateds. The spleens were collected, washed 
twice with sterilized PBS containing 0.8% NaCl, 0.02% KCl，0.289% Na2HPO4, 
0.02% KH2PO4, pH 7.4，and blotted dry with 70% ethanol pre-wetted paper towel. 
Spleens were transferred into the sterilized tissue culture hood，washed twice with 
sterilized basic RPMI 1640 medium (GffiCO). 
Spleens were cut into small pieces and pressed through a 3mL medium pre-
wetted stainless steel grid to yield the splenocytes suspension. The cell suspension 
was centrifuged at 700 x g for 30 seconds to remove cell debris and red blood cells. 
This cmde supernatant was purified by low speed centrifugation using 50% Ficoll 
(Pharmacia Biotech), 4mL supematant in 4mL Ficoll, as support medium at 1,300 x 
g, 18°C for 20 minutes. 
After the density gradient centrifugation, the purified splenocytes lied in the 
yellow layer between Ficoll and medium interface. The cells were collected and 
washed by basic culture medium to reduce Ficoll contamination. The ultimate 
splenocytes were collected by centrifugation at 550 x g for 10 minutes and suspended 
in medium described in the cell culture section. This isolation method yielded a large 
amount ofviable splenocytes (Mishell，B.B. and Shiigi, S.M., 1980). The cell number 
21 
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was determined by hematocytometer (Sigma) by trypan blue exclusion staining. Cells 
(2xl0^) were plated in medium (50pL) on 96-well plates and ready for assay. 
2.1.2 CULTURE OF CELL LENES 
HepG2 (human hepatoma), ECV304 (human umbilical cord endothelial cell), 
L929 (mice fibroblast) were grown in 75-cm^ polystyrene flask (CORNING) in 5mL 
-7mL RPMI 1640 medium (GmCOBRL), pH 7.4，supplemented with 10% fetal 
craft serum, FCS, (GffiCOBRL) and 5% antibiotics containing penicillin and 
streptomycin (GffiCOBRL), complete medium. Cell cultures were maintained in 
85% humidified atmosphere of 5% CO2 and 37。C. On the day of experiment, cells 
were removed from the flasks by 0.25% trypsin-EDTA (GffiCOBRL). They were 
plated at 2.5xl0^ cells per well in 100uL medium (2.5xl0^ cell/mL) on 96-well plates 
(CORMNG). 
2.1.3 iRYPSmZIATION OF CELLS 
The culture medium was removed and cells were washed twice with sterilized 
PBS (2mL). About 0.25% trypsin-EDTA (500^iL) was added. The solution was 
coated evenly on the cell surface and incubated at 37X for 5 minutes. The reaction 
was stopped by FCS supplemented medium. Cell numbers were determined by 
counting using hematocytometer with trypan blue exclusion staining. 
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2.2 PREPARATION OF DRUGS 
All chemicals were freshly prepared before use. 
2.2.1 PREPARATION OF COMMERCDUXY AVAILABLE CHEMICALS 
FOR CELL CULTURE 
Aflatoxin Bi (Sigma) was dissolved in sterile DMSO (BHL) to prepare O.lM 
(5mg AFBi in 161^0. DMSO) in amber bottle and diluted to appropriate 
concentrations by culture medium in 1% DMSO. A 100-fold concentrated AFBi in 
DMSO was made. Ten microliters of concentrated AFBi were diluted to prepare lmL 
solution in 1% DMSO. 
Glycyrrhizic acid (Sigma) and ascorbic acid (Sigma) were accurately 
weighted and dissolved in culture medium in 20mM. The cultured medium should be 
pre-warmed at 45。C with GA. After dissolving the GA, the solution was settled for 30 
minutes. The working solution was sterilize-filtered before assay. 
2.2.2 PREPARATION OF LlCORICE EXTRACTS FOR CELL CULTURE 
The dry Licorice radix roots were brought from local market. Dry roots 
(lOOg) were accurately weighted and were washed twice with distilled water. The 
clean roots were blended in distilled water (lOOmL) at high speed to homogeneity. 
The container was washed twice with distilled water (200mL) to make up a 20% 
(w/v) homogenate. The homogenate (500mL) was collected and boiled at 70。C for 4 
hours, and was filtered through cheese clothes prior to centrifugation at maximum 
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speed to remove the precipitate. The container was pre-weighted and was used to 
collect the clear supematant. The solution was first frozen at -20°C to collect the 
precipitate. The frozen solution was stored at -80。C over night before freeze-drying 
to yield the dry powder of licorice extracts (EX). The weight of the dried extract 
powder was about 2g. The product was stored at 4°C till use (Vora, P.S., and Testa, 
L.C.A.，1997). 
The working solution of the EX was made up by dissolving the powder in 
buffer. The solution was sterilize-filtered before use. 
2.2.3 PREPARATION OF CHEMICALS FOR ENZYMATIC REACTION 
All chemicals were prepared as mentioned above. The only difference was 
that all chemicals were dissolved in the assay medium instead of culture medium, and 
all chemicals were freshly prepared before assay. 
2.3 CYTOTOXICrrY ASSAY METHODS 
Forty-eight hours after plating the cells, the culture medium was discarded 
and replaced by fresh medium containing different concentrations of drugs. After an 
appropriate period of incubation time at a 85% humidified atmosphere of 5% CO2 
and 37。C，the cell viability was monitored by MTT assay or Neutral Red assay. 
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2.3.1 MTT ASSAY 
Methylathiazol tetrazolium (MTT) from Sigma was dissolved in phosphate 
buffer saline, PBS, to prepare 5mgy^ mL solution. The MTT solution was filtered every 
2 months by 45^im pore size filter paper. The MTT solution was stored at 4 ¾ in dark. 
A concentrated stock solution was not recommended. 
The culture medium was discarded and the cells were washed twice with PBS 
(lOO^iL). Then MTT solution (50^iL) was added to each well. The plates were 
incubated for 2 hours at 3TC. The incubation duration was cell line specific. DMSO 
(150^iL) was added to each well and they were incubated for 30 minutes before the 
O.D. at 540nm was recorded by an ELISA plate reader (BIO-RAD) (Berridge, M.V., 
and Tan, A.S.，1993 and Supino，R., 1995). 
2.3.2 NEUTRAL RED ASSAY 
Neutral red (Sigma) was dissolved in normal saline containing 0.9% NaCl to 
prepare 0.5% solution. The neutral red solution was filtered through 45^im pore size 
filter paper to remove the NR residue. The working solution was filtered again every 
2 months to remove precipitates and stored at room temperature till used. A 
concentrated stock solution was not recommended. 
The culture medium was discarded and the cells were washed twice with PBS 
(lOO^iL). Then neutral red solution (50piL) was added to each well. The plates were 
then incubated for 1 hour at 3TC. After incubation, the staining solution was 
removed and washed twice with HANK'S solution (lOO^iL). The plates were dried at 
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65^C for 4 hours. Cells were lysed with 1% SDS solution and the O.D. at 540nm was 
measured by an ELISA plate reader immediately (Riddell, R.J.，Clothier, R.H., and 
Balls, M., 1986). 
In order to determine the cell number in each assay, the relationship between 
the cell number and the detection signal was established. Different cell numbers were 
used to develop the calibration curve. A linear relationship between cell number and 
the detected signal was established in both assays as shown in Figure 2.1-2.5. 
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2.4 CYTOTOXICrrY ASSAY 
In the time-course studies, cells were incubated in different concentrations of 
reagents (GA, AA, EX and AFBi) for 24-hour, 48-hour, 72-hour and 96-hour, 
respectively. The concentrations used were listed below. The control contained drug 
free medium only. 
1. [GA] = l^iM, 5^iM，lO^iM, 50^iM, lOOpM, 250^M, 500^iM & 1 0 0 0 _ ; 
2. [AA] = l^iM, 5^iM, lO^iM, 50^iM, lOO^iM, 250^iM, 500^iM & 1000^iM; 
3. pEX] = l^ig/mL, 5^ig/mL, lO^igAnL, 50|igAnL, lOO^igAnL，250ngAnL, 500 i^gy^mL 
& lOOOngAnGL; 
4. [AFBi] 二 0.5^dV^ l^iM, 5^iM, lO^iM, 50^iM, lOO^iM & 200^iM in 1% DMSO 
2.5 CHEMOPROTECTION ASSAY 
Cells were cultured in 6-well plates (CORMNG) as described in the above till 
90% confluence. Glycyrrhizic acid, ascorbic acid and licorice extract (EX) were 
added according to the following protocols. The cell viability was determined by 
Neutral Red assay. 
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Drug concentrations used were: 
1. [GA]=聯,5^ iM , lO^iM, 5 0 _ , lOO^iM & 2 5 0 _ ; 
2. [AA] = l^M, 5_， lO^M, 50^iM, 100pM & 250^^¾ 
3. [EX] = l^ig/mL, 5^ig/mL, lO^ig/mL, 50^ig/mL, lOO^ig/mL & 250^igAnL; 
4. [AFBi] = 5^iM, lO^M, 25^iM, 50^iM, lOO^iM & 200jxM in 1% DMSO 
For all chemoprotection assays, the solutions of GA-APBi, AA-AFBi and EX-AFBi 
were prepared. 
2.5.1 DlRECT ADDITION OF DRUGS 
Cells were cultured in normal medium till confluence as described above. 
After 48 hours plating of cells, the medium was discarded and aflatoxin and drug-
containing medium (200^iL) were added and incubated for another 48 hours. The 
results were compared with the control containing no drugs but AFBi only; no AFBi 
but drugs only. 
2.5.2 PRETREATMENT OF CELLS 
Cells were cultured in normal medium till confluence. After plating of cells, 
the drug-containing medium (200^iL) was added and incubated in humidified 
incubator at 37°C for 24 hours and 48 hours, respectively. After the pretreatment with 
incubation, the culture medium was discarded and aflatoxin and drug-containing 
medium (200^d^) were added and incubated for another 48 hours. The results were 
compared with cells treated with drugs only and with untreated cells. 
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2.5.3 CULTURE OF CELLS WTTH DRUGS 
Cells were cultured in drug-containing medium for 4 days in 6-well plate, 
about 80-90% confluence. The amount of cell harvested was almost the same at all 
drug concentrations. Cells were plated for 48 hours in drug-containing medium. On 
the day of experiment, the culture medium was discarded and aflatoxin and drug 
containing medium was added and incubated for another 48 hours. The results were 
compared with cell cultured in drugs only and with untreated cells. 
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2.6 PREPARATION OF ENZYME 
2.6.1 PREPARATION OF CELLS 
Cells were cultured in 75-cm^ flasks as described above till 90% confluence. 
Then cells were collected and washed twice with PBS. Cells were suspended in ice-
cold buffer containing 25% glycerol, O.lmM EDTA, O.lmM DTT, lOmM Tris-HCl, 
pH 7.2. The following procedures were carried out at 4°C. The cell suspension was 
sonicated for 30 seconds at 5 seconds interval, centrifuged at 90,000 x g for 45 
minutes. The supernatant was recentrifuged to yield a more purified fraction. The 
supernatant was stored at -80°C till assay. The protein content of the samples was 
determined by Bradford assay (Habig, W.H. and Pabst, MJ. , 1974 and Duthie, S.J., 
Coleman, C.S., and Grant, M.H., 1988). 
2.6.2 PREPARATION OF RAT MlCROSOMES 
Female Wistar rats aged 2 months, weighing 150-200g, were scarified. The 
liver was collected, washed twice with ice cold homogenizing buffer containing 
0.25M sucrose, O.lmM DTT, O.lmM EDTA, 76mM Na2PO4, lOmM Tris-HCl, 
pH7.4, weighted and blotted dry, then cut into small pieces to make up a 20% (w/v) 
suspension. The following steps were all carried out at 4^C. The suspension was 
homogenizied with Telfon homogenizer. The homogenate was centrifuged at 2,000 x 
g for 30 minutes to remove nucleus and cell debris. The supernatant was 
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recentrifuged at 100,000 x g for 90 minutes to sediment the microsome. The 
microsome was further purified by centrifugation at 100,000 x g for another 90 
minutes. The microsomal pellet was resuspended in buffer containing 25% glycerol， 
O.lmM DTT, O.lmM EDTA, 76mM Na2PO4, lOmM Tris-HCl，pH7.4. The protein 
content of the microsomal fraction was determined by Bradford assay and stored at 
-80^C till assay. 
2.7 BRADFORD ASSAY 
The protein standard curve was established using bovine serum albumin 
(BSA) standard (Sigma) with lngAnl, 2ng/mL, 5ngy'mL and lOng/mL protein as 
shown in Figure 2.6. The Bradford protein dye (BIO-RAD) was used. Protein 
standard (800^dL) and protein dye (200^d>) were incubated at room temperature for 5 
minutes and recorded at O.D. 595nm. The cell fraction was diluted to 200 to 1,000 
folds with distilled water for protein assay. The rat microsomal fraction was diluted to 
10,000 fold in distilled water for the protein assay (Bradford, M.M., 1976). 
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2.8 ALKOXYRESORUFm 0-DEALKYLASE ASSAY 
. 7-Ethoxyresorufm (ER), methoxyresorufin (MR), resorufin (RR) and NADPH 
were obtained from Sigma. ER and MR were substrates employed for reaction. 
P450s have different specific activities towards different substrates. However, RR is 
the common product of these substrates. 
ER (lmg) was dissolved in absolute methanol (4.14mL) to yield ER 
suspension, which was allowed to settle for a while. The solution was diluted to 100-
500 fold with reacting medium and the concentration was optically measured at 
482nm against the bufFer blank (s482nm = 22.5 mM'^cm"^). The suspension was diluted 
to an appropriate concentration with buffer. 
MR and RR were dissolved in absolute methanol to make up a stock solution. 
RR (O.lmg) was dissolved in methanol (5.33mL) to prepare 80jiM. The solution was 
diluted to 5000 fold with the reacting medium and the concentration was optically 
measured at 571nm against the bufFer blank (s57inm = 54mM"^cm'^). The suspension 
was diluted to an appropriate concentration with buffer. MR (lmg) was dissolved in 
methanol (14.3mL) to prepare 300^iM solution. All solutions were stored at -20°C till 
use, and the methanol concentration was less than 1%. 
Alkoxyresorufin and 0-dealkylase activities in Wistar rats' microsomal 
fractions were measured. Since it failed to measure the enzyme activity in isolated 
fractions, this assay was applied to hepatomicrosomal fractions from the Wistar rat 
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only. The substrate concentration employed was 1.5^iM in <0.1% methanol and the 
reacting medium containing lmM NADPH in 50mM Tris-NaOH, pH 7.8. Five 
millimolars NADPH (40^iL), reacting medium (95^iL) and 0.5mg/mL protein (50^iL) 
were added to the 96 well-plate. Twenty micromolar substrate (15^iL) were finally 
added to initiate the reaction. 
The fluorescence of the reacting cell was measured at an excitation 
wavelength of 590nm and emission wavelength at 530nm. The blank contained no 
enzyme. The reaction was monitored fluorometrically for 10 minutes at 2 minutes 
interval. The reaction rate was determined against RR standard curve. The RR 
standard curve was made up with zero pmol to 150pmol RR in reaction medium as 
shown in Figure 2.7. The specific activity of the reaction was nmol resorufin 
formed/min/mg protein. In order to establish the effective reaction rate, different 
amounts of protein were used for the assay. The calibration curves were shown in 
Figure 2.8 and Figure 2.9 (Pohl, R.J. and Fotus, J .R, 1980; Klotz, A.V., Stegeman 
J.J., and Walsh, C., 1984; Grant, M.H etal., 1993; Doostdar, H. etaL, 1993). 
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2.8.1 EFFECTS OF AFBi ON P450 
Different amounts of AFBi were diluted with the reacting medium in 1% 
DMSO. AFBi were added directly to enzymes and the fluorescence was monitored 
immediately at room temperature for 10 minutes at 2 minutes interval. Enzymes were 
incubated with different amounts ofAFBi at 37°C for 10 minutes, 20 minutes and 30 
minutes, respectively to study prolong exposure effects of AFBi on P450. 
2.8.2 EFFECTS OF DRUGS ON P450 
Different amounts of drugs were added to the reacting medium to study the 
direct addition effects of drugs on the P450. All drugs were accurately weighed and 
freshly prepared in the reacting medium before assay. Also, the drugs were incubated 
with the enzyme at 37。C for 10 minutes, 20 minutes and 30 minutes. 
2.9 GLUTATHIONE-S-TRANSFERASE ASSAY 
Reduced glutathione (GSH), 1 -chloro-2,4-dinitrobenzene (CDNB), were 
obtained from Sigma. CDNB was substrate employed for reaction. The absorbance of 
the product was measured at 340nm. GSH was a peptide combined with CDNB to 
form a more hydrophilic compound in favor of the GST reaction. 
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GSH (0.06146g) was accurately weighed and dissolved in the reacting 
medium (9.8mL) containing 0. lM potassium phosphate buffer, pH 6.5. The pH was 
adjusted with 2M potassium hydroxide (200^iL), CDNB (0.08g) was dissolved in 
ethanol (4mL) to prepare 100mM solution. 
The GST was isolated from cells and the Wistar rat microsomal fractions 
according to described method. GSH (20uL 20mM) and enzyme (lO^L) were added 
to the reacting medium (960uL). This mixture was incubated at 37。C water-bath for 1 
minute. CDNB (lOuL lOOmM) was used to initiate the reaction. The absorbance of 
the cell was measured at 340nm for 1 minute at 5 seconds interval. The final volume 
was lmL. The concentration of GSH and CDNB in 1% ethanol. A complete assay 
mixture without enzyme was used as the control to monitor the non-specific binding 
of GSH to CDNB. The specific activity of the reaction was nmol product formed 
/miny^mg protein. In order to determine the effective reaction rate, different amounts 
of protein were used for the assay. The calibration curves were shown in Figure 2.10 
and Figure 2.11 (Habig, W.H. and Pabst, M.J., 1974 and Duthie, S.J., Coleman, C.S., 
and Grant, M.EL, 1988). 
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2.9.1 EFFECTS OF AFBi AND DRUGS ON GST E^ RAT MlCROSOMAL 
FRACTIONS 
2.9.1.1 EFFECTS OF AFBi ON GST 
It was found that AFBi in DMSO would influence the absorbance of the assay 
mixture. Therefore, 100 fold dilution of the concentrated enzyme was incubated with 
different amounts of AFBi in 1% DMSO for up to 45 minutes at 37^C. After 
incubation, the enzyme was diluted with the reaction medium. AFBi was dissolved in 
methanol for assay. 
2.9.12 EFFECTS OF DRUGS ON GST 
Different amounts of drugs were added to the reacting medium for the 
measurement of the direct addition effects of drugs on GST. All drugs were freshly 
prepared in the reacting medium before assay. Also, the drugs were incubated with 
GST at 37°C for 10 minutes to 45 minutes to study the effects of drugs on GST. 
2.9.2 EFFECTS OF AFBi AND DRUGS ON GST m FRACTIONS FROM 
CELLS 
2.9.2.1 DlRECT ADDITION EFFECTS OF DRUGS ON GST 
The assay method was the same as for the rat microsomal fractions. The 
enzymes were substituted for fractions from cells. It failed to examine the direct 
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addition effects ofAFBi on GST. Therefore, only the direct addition effects of drugs 
were observed. 
2.9.2.2 EFFECTS OF DRUG-CONTAmES[G MEDIUM ON GST 
Cells were cultured in different amounts of drugs for 4 days. The culture 
conditions were the same as the chemoprotective assay. On the day of experiment, 
cells were harvested and the samples were prepared as described above. Cells were 
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RESULTS 
Chapter Three CELL CULTURES 
Objectives: CYTOTOXICrTY ASSAY 
To study the cytotoxic effects of AFBi on cells and test if GA, AA or 
EX were toxic; to determine the effective concentration range of drugs 
used for chemoprotection test. 
CHEMOPROTECTION ASSAY 
To study the protective ability of GA, AA or EX towards AFBi 
intoxicated cells. Three different treatments were employed: 
i. Direct addition of drugs to cells, 
ii. Pretreatment of cells, and 
. iii. Culture of cells 
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3.1 CYTOTOXICITY ASSAY 
3.1.1 CYTOTOXICITY OF AFB i 
The cytotoxicity of AFBi to different cells would be studied before the 
chemoprotection assay was carried out. Different amounts of AFBi were incubated 
with cells for different periods of time in order to determine the LC50 of AFBi, lethal 
concentration ofAFBi that caused 50% cell death. Since AFBi was non-toxic itself, 
metabolic activation ofAFBi was needed. Therefore, the incubation time should be 
tested to allow metabolic activation for developing the LC50. Different cells, freshly 
isolated splenocytes, HepG2, L929 and ECV304 were used to study AFBi cytotoxic 
effects. Splenocytes and AFBi were incubated for 24 hours only，whereas cell lines 
and AFBi were incubated for 24 hours, 48 hours, 72 hours and 96 hours, respectively. 
3 • 1 • 1.1 CYTOTOXICITY OF AFB 1 ON SPLENOCYTES 
MTT assay was employed to measure the viability of splenocytes. The 
incubation time for AFBi intoxication study was 24 hours. Cells (2xl0^) were 
incubated with different concentrations of AFBi. It was found that the relative 
viability of splenocytes increased at higher AFBi concentration. The results were 
shown in Figure 3.1. However, when trypan blue exclusion staining assay was used to 
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determine the viability of AFBi treated splenocytes, the L C 5 0 was about 50^iM as 
shown in Figure 3.2. 
This discrepancy was due to the influence of AFBi on MTT assay. Therefore, 
MTT assay was also carried out using HepG2 as the control. Similar results were 
obtained in Figure 3.3. Apart from cells, freshly isolated mitochondria were also used 
for the study. The preparation of mitochondria was described previously (Hogeboom, 
G.H. etal.，1947 and Kielley, W.W. and Kielley, R.K., 1952). The crude fractions of 
mitochondria were incubated with AFBi to see if the mitochondria were activated by 
AFBi to reduce MTT. The results were shown in Figure 3.4. There was more 
formazan obtained at higher AFBi concentration in samples. 
It was very difficult to culture freshly isolated splenocytes. The viability 
dropped virtuously to < 70% after one day. Thus, cell lines were employed to study 
the AFBi cytotoxicity. 
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Figure 3-1 Effects ofAFBi on Wistar rat splenocytes measured by 
MTT assay 
Freshly isolated Wistar rat splenocytes were cultured in RPMI 1640 medium and 
supplemented with 10% FCS and 5% antibiotics. They were plated out at 2xl0^ cells per well 
in 96-well plates, and incubated at humidfied atmosphere at 37°C and 5% CO2. AFBi which 
was dissolved in DMSO was added lOO i^L to each well. The cells were then incubated under 
the same condition for 24 hours. The cell viability of the remaining cells was measured by (a) 
MTT assay (Figure 3.1) and (b) Trypan-blue exclusion assay (Figure 3.2). The data were 
converted to percent of cell viability with reference to the control in which no AFBi was 
added. Vertical bar represented one standard error for the following assays. 
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Figure 3-2 Effects ofAFBi on Wistar rat splenocytes measured by 
trypan-blue exclusion assay 
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Figure 3-3 Effects ofAFBi on HepG2 measured by MTT Assay 
Human hepatoma cells (HepG2) were plated out at 2xl0^ cells per well in 96-well 
plates. AFBi dissolving in DMSO was added lOO^L per well. The cells were then 
incubated for 24 hours. The medium was discarded and the cells were washed twice 
with PBS. MTT assay was used to measure the cell viability. 
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Figure 3-4 Effects ofAFBi on mitochondria measured by MTT assay 
Freshly isolated Wistar rat mitochondria were suspended in the reacting medium. 
They were plated out at O.lmg protein per well in 96-well plates, and incubated at 
humidfied atmosphere at 3TC and 5% CO2. AFBi in DMSO was added lOO i^L to 
each well. The mitochondria were then incubated under the same condition for 24 
hours. MTT assay was used to measure the mitochondrial activity. 
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3.1.12 CYTOTOXICITY OF AFB i ON CELL L ^ES 
HepG2 (human hepatocarcinoma), L929 (mice fibroblast) and ECV304 
(human umbilical cord endothelial cell) were used to study AFBi cytotoxicity. 
HepG2 is a cancer cell line where L929 and ECV304 are not. L929 and ECV304 
were employed for comparing different cellular responses. Cells (2.5xlO^) were 
incubated with different concentrations of AFBi for 24 hours, 48 hours, 72 hours and 
96 hours, respectively. The LC50 of AJFBi for different cell lines were shown in 
Figure 3.5-3.7. The cytotoxic effects of AFBi was summarized in Table 3.1. AFBi 
was toxic to both freshly isolated splenocytes and cell lines. The LC50 of AFBi for 
splenocytes was about SO^M. 
Comparing the values of LC50, the primary cell cultures were more sensitive 
to AFBi intoxication. Cancer cell line was less susceptible to AFBi cytotoxicity. 
Based on the above findings, cultured cell lines were employed as a model for the 
intoxication study of AFBi. 
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Figure 3-5 Time-course study of AFBi cytotoxic effects on HepG2 
Cells were grown in RPMI 1640 medium. Different cell lines were used (a) HepG2 
(Figure 3.5)，(b) L929 (Figure 3.6) and (c) ECV304 (Figure 3.7). They were plated 
out at 2xl0^ cells in each well of 96-well plates, and incubated at humidfied 
atmosphere at 37。C and 5% CO2. AFBi dissolving in DMSO was added 200^iL per 
well. The cells were then incubated under the same condition for 24 hours, 48 hours, 
72 hours and 96 hours, respectively. NR assay was used to measure the cell viability 
of the remaining cells. O.D. at 540nm was used to calculate the cell viability. 
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Figure 3-6 Time-course study of AFBi cytotoxic effects on L929 
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Figure 3-7 Time-course study of AFBi cytotoxic effects on ECV304 
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Table 3.1 LC50 of AFBi for different cell lines 
HepG2 L ^ ECV304~~~ 
24-hour >200^iM -200^iM -200M-M 
48-hour 121^iM 66pM 41^ dV[ 
72-hour 90^iM 21nM 27^lM 
96-hour 63^iM 23.5piM 22\iM 
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3 • 12 CYTOTOXICITY OF DRUGS TO CELL L^ES 
In order to check for the chemoprotective ability of drugs against AFBi 
cytotoxicity, the no observed effect level O^OEL) of the drugs was determined to 
study the drug effects on cells. Different concentrations of AA, GA and EX were 
incubated with cells for 24 hours, 48 hours, 72 hours and 96 hours, respectively to 
obtain the NOEL of each drug. The relative cell viability was shown in Figure 3.8-
3.16. 
The results showed no adverse effects of GA on cells. The viability ofHepG2 
exceeded 80% even when cells were incubated at lmM GA for 96 hours (Figure 3.8). 
The viability ofL929 dropped to 80% at lmM GA after 24 hours incubation ( Figure 
3.9). The viability ofL929 dropped to 60% after 96 hours incubation at lmM GA. 
The effects of GA on ECV304 were independent of its incubation time. No 
significant difference was found between 24 hours incubation and 96 hours 
incubation. The cell viability was about 60% at lmM GA. It stayed high at other 
concentrations. 
Severe cell death was observed when cells were incubated at high 
concentration of EX. There was no significant difference found between the control 
and EX-treated cells even when cells were incubated with 500^igAnL EX. However, 
the cell viability dropped below 10% at lmg/mL EX (Figure 3.11). Similar results 
were obtained with L929 and ECV304. The viability ofL929 and ECV304 was not 
72 
ResuUs of Cytotoxicity Assay 
a a c — B H ^ ^ n » — — — — i — — — ‘ 
affected till the concentration o f E X reached 500^ig/mL (Figure 3.12 and Figure 
3.13). 
Other experiments were carried out using AA. The viability of HepG2 was 
not affected till the concentration of AA reached 500^M. The assay was incubated for 
72 hours (Figure 3.14). About 50% cell death was measured when L929 was 
incubated with lmM AA for 24 hours, 48 hours and 72 hours. After 96 hours of 
incubation, the viability ofL929 dropped to 75% at low AA concentration (<500^iM) 
(Figure 3.15). The viability ofECV304 was not affected till the concentration of AA 
reached 250pM. The effect was similar to that of the incubation study (Figure 3.16). 
In conclusion, the concentration of drugs employed would not exceed 250^iM 
for AA, SOO^M for GA and 500^ig/mL for EX. Under these concentrations, the 
viability of all cell types was similar. 
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Figure 3-8 Effects of GA on HepG2 
Three cell lines, (a) HepG2 (Figure 3.8, Figure 3.11 and Figure 3.14), (b) L929 
(Figure 3.9，Figure 3.12 and Figure 3.15) and (c) ECV304 (Figure 3.10, Figure 3.13 
and Figure 3.16) were used to study the effects of GA, EX and AA on AJFBi. They 
were plated out at 2xl0^ cells in each well of 96-well plates. The respective agents 
were dissolved in the same medium. The same amount (200^iL) was pipetted out in 
each well. The cells were then incubated for 24 hours, 48 hours, 72 hours and 96 
hours，respectively. NR assay was used to the measure cell viability. 
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Figure 3-9 Effects of GA on L929 
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Figure 3-10 Effects of GA on ECV304 
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Figure 3-11 Effects of EX on HepG2 
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Figure 3-12 Effects of EX on L929 
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Figure 3-13 Effects of EX on ECV304 
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Figure 3-14 Effects of AA on HepG2 
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Figure 3-16 Effects of AA on ECV304 
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3.2 CHEMOPROTECTION ASSAY 
Drugs and AFBi were incubated with cells. Three different treatments on cells 
were studied. 
i. Direct addition of drugs to AFBi-intoxicated cells, 
ii. Cells were pre-treated with drugs for 24 hours and 48 hours, respectively, 
before AFBi intoxication, 
iii. Cells were cultured in drug-containing medium (AA, GA or EX) for 4 days 
before AFBi intoxication. 
Though different concentrations of drugs were employed. No statistical 
difference was found at different concentrations of drugs. Similar results were 
obtained when the concentrations of drugs were between l^iM to 250^M for AA and 
GA, and l^igAnL to 250n^gAnL for EX. Therefore, only the lowest concentration of 
drugs was used in the experiment. 
3.2.1 DlRECT ADDITION OF DRUGS 
Drugs were directly added together with AFBi to cells. The control sample 
did not contain drugs but AFBi only, and cells that were not exposed to both drugs 
and AFBi. The results ofthe direct addition ofl^dVl GA, l\xM AA and l^ig/mL EX to 
different cell lines were shown in Figure 3.17-3.19. 
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The viability of HepG2 was similar between drug-treated cells and AFBi-
intoxicated cells at mild AFBi intoxication. The percentage of viability revived was 
about 20% by incubating with l^iM AA at 200^iM AFBi intoxication. The percentage 
of viability with EX and GA were alike about 10% at 200^iM AFBi intoxication 
(Figure 3.17). 
More than 30% ofthe cell viability was improved by l^iM AA pretreatment 
of200^iM AFBi-intoxicated L929. The protective effect was greatest at 50^iM AFBi 
intoxication. The chemoprotective effects of GA and EX were alike but were lower 
than AA. About 10% of the viability was revived by EX and GA in 200^iM AFBi-
intoxicated L929 samples (Figure 3.18). 
The chemoprotective ability of AA, GA and EX was about the same for 
ECV304. About 10% revival ofthe cell viability was recorded at lOO^iM and 200pM 
AFBi. The revival of cell viability was highest at 50^iM AFBi-intoxicated samples. 
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Figure 3-17 Direct addition effects of drugs on HepG2 against 
cytotoxicity of AFBi 
Three cell lines, (a) HepG2 (Figure 3.17), (b) L929 (Figure 3.18) and (c) ECV304 
(Figure 3.19) were plated out 2xl0^ cells in each well of 96-well plates. GA, AA and 
EX (200n-L) in the AFBi containing medium was added to well. The cells were then 
incubated for 48 hours. NR assay was used to the measure cell viability. 
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3.2.2 PRETREATMENT OF CELLS WTTH DRUGS 
Cells were pretreated with different amounts of drugs for 24 hours and 48 
hours before incubation with AFBi for 48 hours. The control group was pretreated 
with drugs only but was not intoxicated by AFBi. No significant difference of cell 
viability was obtained during the 24 hours and 48 hours pretreatment process and the 
AFBi treatment process. Therefore, only the results of cells pretreated with drugs for 
24 hours were reported. The chemoprotective ability of drugs was shown in Figure 
3.20-3.22. 
• The protective effects of AA and EX pretreatment on HepG2 were not 
obvious with mild AFBi intoxication (<50M-M). The revival of cell viability was 
highest (about 10%) with 200MM AFBi intoxication. After sever AFBi intoxication, 
EX-pretreated HepG2 and AA-pretreated HepG2 were more resistant to 200^iM 
AFBi comparing to GA-pretreated cells. The revival of cell viability was 26% and 
28%, respectively (Figure 3.20). 
The results of L929 pretreated in AA-containing medium were found to be 
more tolerant to mild AFBi intoxication than cells pretreated in other drug-containing 
medium. However, the protection was able to revive 10% viability in sever AFBi 
intoxication (200^iM). The results of GA-pretreated L929 and EX-pretreated L929 
were similar. 20% of cell viability was revived by EX and about 30% by GA with 
mild intoxication (50^iM AFBi). The revival was about 10% by both drugs in sever 
intoxication (200^iM AFBi) showed in Figure 3.21. 
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The viability of ECV304 was increased by 20% after pretreatment in AA-
containing medium at all AFBi intoxication. The chemoprotective ability was similar 
to that using GA. The EX-pretreated ECV304 was tolerant to mild AFBi intoxication 
(25^iM). The cell viability exceeded 80%. However，sever cell death was found at 
high AFBi concentration (200^dVQ. The viability was <25% with 10% revival by 
drugs. The GA-pretreated ECV304 and AA-pretreated ECV304 showed similar 
response in all AFBi intoxication (Figure 3.22). 
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Figure 3-20 Cytotoxic effects of AFBi on HepG2-pretreated with drugs 
for 24 hours 
Three cell lines, (a) HepG2 (Figure 3.20), (b) L929 (Figure 3.21) and (c) ECV304 
(Figure 3.22) were used to study effects of drugs-containing medium on cell viability 
for 24 hours. They were plated out at 2xl0^ cells in each well of 96-well plates. GA, 
AA and EX (200^iL) which were dissolved in the AFBi containing medium was 
added in well. The cells were then incubated under the same condition for 48 hours. 
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Figure 3-22 Cytotoxic effects of AFBi on ECV304-pretreated with 
drugs for 24 hours 
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3.2.3 CULTURE OF CELLS WTTH DRUGS 
Cells were cultured in drug-containing medium for 4 days. Subsequently, cells 
were transferred to aflatoxin and drug-containing medium for another 48 hours. The 
amount of cell harvested was almost the same in all different concentrations. This 
indicated that drugs would not influence the cell growth. 
The results of drugs-cultured HepG2 were shown in Figure 3.23. The L C 5 0 of 
AFBi to AA-cultured cells increased from 121^iM to about 200^iM. Drugs-cultured 
HepG2 were more tolerant to AFBi intoxication. After the cells were incubated in 
GA-containing medium or EX-containing medium, the viability was improved by 
32P/o up to 70% and 83%, respectively, even when cells were exposed at 200^iM 
AFBi. This indicated that treated cells were more tolerant to the AFBi cytotoxic 
effects than untreated cells. Amongst the three drugs-cultured cells, EX showed better 
protection. The cell viability exceeded 80% at all APBi concentrations. 
The drugs-cultured L929 and ECV304 were found more tolerant to AFBi 
cytotoxicity. The viability remained high even with sever AFBi intoxication 
(lOOp,M). However, the LC50 of the AFBi exceeded 200^iM with drugs-cultured L929 
and ECV304 ^^igure 3.24 and Figure 3.25). 
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Figure 3-23 Effects of drugs-containing medium on HepG2 towards 
cytotoxicity of AFBi 
Three cell lines, (a) HepG2 (Figure 3.23), (b) L929 (Figure 3.24) and (c) ECV304 
(Figure 3.25) were used to study effects of drugs-containing medium for 4 days. They 
were plated out in 96-well plates, and incubated at 37^C. GA, AA and EX (200pL) 
which was dissolved in AFBi-containing medium was added to well. The cells were 
then incubated for 48 hours. NR assay was used to measure the cell viability. 
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Figure 3-24 Effects of drugs-containing medium on L929 towards 
cytotoxicity of AFBi 
85 
Results of Chemoprotection Assay 
^ ^ ^ _ ^ ^ ^ _ _ _ _ . ^ ^ ^ _ _ ^ _ ^ ^ ^ ^ _ ^ — „ i p i ^ p ^ e e , ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ M e : M B e e a 8 i i ^ ^ ^ ^ ^ ^ ^ ^ B a g ^ ^ ^ a ^ = 8 i ^ ^ = ' i ^ ^ g s ^ ^ = ' * ^ ° 
• Control • 1 uM AA 四 1 ug/mL EX 四 1 uM GA 
1 4 0 ^ ： — 
120 
1 。 。 n f c ^ i h f i " " ^ ! " ^ ^ - ： ^ ^ — 
S 30 - _ _ f _ _ T | i J i K | i M f ~ " ~ " t 
6 。 - 1 - 1 - T I - i - _ 
J . i= _ _ _ _ 
Control 5uM 10uM 25uM 50uM 100uM 200uM 
• QControl 100.00 9^~~ 86.68 73.63 42.67 33.14 17.01 
• 1uMAA 0^000 9 ^ ~ 106.94 90.83 92.08 87.27 53.28 
Slug/mLEX ^0^~~ 104.59 "l03.42 106.48 100.45 “ 91.00 65.37  
Ug1uM GA 100.00~~ 104.47 105.31 101.82 103.49 83.66 79.47 
AFB 1 Concentration 
Figure 3-25 Effects of drugs-containing medium on ECV304 towards 
cytotoxicity of AFBi 
86 
CHAPTER FOUR 
ENZYM ATIC ASSAYS 
•* 
ResuUs of Enzymatic Assay 
Chapter Four ENZYMATIC ASSAYS 
Objectives: To study the enzymes involved in the metabolism of AFBi in the 
presence of phytochemicals; the toxic effects of AFBi； the effects of 
GA and EX on P450s which are responsible for the activation of 
AFBi； the effects of GA and EX on GST which is responsible for 
removing toxic metabolites of AFBi. 
P450s were believed to be the major enzyme system responsible for AFBi 
bioactivation leading to the formation of toxic metabolites, and GST was found to 
remove the majority of toxic compounds. Therefore, this study may provide 
information on the chemoprotection mechanism of the phytochemicals against AFBi 
cytotoxicity. The drug protective ability was established in the previous chapter. 
Thus, alkoxyresorufin 0-dealkylase assay (only EROD and MROD) and GST assay 
were employed for monitoring the effects of drugs on P450s and GST, respectively. 
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4.1 ALKOXYRESORUFm 0-DEALKYLASE ASSAY 
Though the speeific isoform of P450s responsible for AFBi metabolism was 
still not clear. Scientists believed that CYPlA, CYP2A and CYP3A were the major 
isoforms involved. Therefore EROD and MROD assays were employed. 
Unfortunately, the method failed to measure the enzyme activity in whole cells or 
fractions isolated from cultured cells mentioned in the previous chapters. Therefore, 
only rat microsomal samples were used to study the effects. 
4.1.1 EFFECTS OF AFBi ON P450s 
The effects ofAFBi on P450s were shown in Figure 4.1 and Figure 4.2. In 
both EROD and MROD assays, the enzyme activities were inhibited by direct 
addition ofAFBi. The activities of P450s were not affected till the concentration of 
AFBi exceeded lO^M. The activity was inhibited in the presence of AFBi added. 
Close to 9% ofthe relative specific activity was inhibited by 200^iM AFBi in MROD 
assay and 3% by EROD assay. These findings were shown to be statistically 
significant. 
For the prolonged incubation of AFBi on P450s, similar results were 
observed. The relative specific enzyme activity measured by EROD assay was further 
inhibited by APBi by another 5% after 30 minutes incubation at 37X, but the 
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difference was not statistically significant comparing to the sample without 
incubation. The results were shown in Figure 4.1. When MROD assay was used, 
about 16% of the enzyme activity was significantly inhibited by AFBi at 200^iM 
AFBi after 30 minutes incubation showed in Figure 4.2. The inhibitory effects were 
more sever for longer incubation duration. However, there were no effects recorded 
when the AFBi concentration was lowered than lO^JM. It was believed to be the 
threshold of AFBi toxicity. 
The inhibitory effects of AFBi were directly proportional to the AFBi 
concentration and the exposure duration. For a longer incubation period and higher 
AFBi concentration, the inhibitory effects were greater. Moreover, the effects of 
AFBi were not specific. 
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Figure 4-1 Incubation effects ofAFBi on P450s by EROD Assay 
For microsomal assays, experiments were carried out as follows: Microsomes were 
prepared from rats. About 25^ig protein was added in a 96-well plate, and incubated 
with AFBi at 37°C for 0 minutes, 10 minutes, 20 minutes and 30 minutes, 
respectively. ER and MR (20^iM) were used as substrate to initiate the reaction. The 
fluorescence of the assay cell was measured at an excitation wavelength of 590nm 
and an emission wavelength at 530nm for 10 minutes at 2 minutes interval. The 
fluorescence intensity was converted to specific activity with reference to the control 
in which no drugs was added. The results ofEROD assay were shown in Figure 4.1 
and the results ofMROD assay were shown in Figure 4.2. 
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Figure 4-2 Incubation effects of AFBi on P450s by M R O D Assay 
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4.12 EFFECTS OF GA ON P450s 
The activities of P450s were slightly activated by GA. In EROD assay the 
activation was about 10% at lOO^iM. The activity dropped to normal at high 
concentration (lmM). The enzymatic activity was significantly activated by GA after 
incubation at 37。C. The activation varied with the GA exposure duration. The 
activation was about 40% after half an hour incubation at lOO^iM GA. The results 
were shown in Figure 4.3. 
Opposite results were found for MROD assay. No significant difference was 
found till the GA concentration reached lOO^iM. The relative specific activity (10%) 
was inhibited at lmM GA. The enzyme activity was first inhibited by low 
concentration of GA and subsequently raised to the normal level after incubation at 
high concentration of GA. The enzyme activity was not affected by GA even it was 
incubated for half an hour (Figure 4.4). 
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GA Concentrat ion (uM) Figure 4-3 Incubation effects of GA on P450s by EROD Assay 
For EROD assay, microsomes were prepared from rats. About 25^ig protein was 
added in 96-well plate, and incubated with GA at 3TC for 0 minutes, 10 minutes, 20 
minutes and 30 minutes, respectively. The results of EROD assay were shown in 
Figure 4.3 and the results ofMROD assay were shown in Figure 4.4. 
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Figure 4-4 Incubation effects of GA on P450 by M R O D assay 
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4.1.3 EFFECTS OF EX ON P450S 
To study the effects of EX on P450s, the formation of products in 
experimental samples was less than that of the control. This indicated that the P450s 
were inhibited by EX at lmg/mL. About 20% activity was inhibited in EROD assay 
(Figure 4.5). The inhibitory effects were more severe after incubation at 37°C. The 
relative specific activity was about 60% in EROD assay after incubation at lmg/mL • 
EX for half an hour. 
In MROD assay, 10% of the activity was inhibited by EX. The inhibitory 
effects were independent of the concentration shown in Figure 4.6. The relative 
specific activity was about 50% at lmg/mL EX with 30 minutes incubation at 3TC. 
In both assays, the inhibitory effects increased with the incubation times. 
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Figure 4-5 Incubation effects EX on P450s by EROD Assay 
The method for MROD assay was the same as the EROD assay described earlier. The 
results of EROD assay were shown in Figure 4.5 and the results of MROD assay 
were shown in Figure 4.6. 
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Figure 4-6 Incubation effects of EX on P450s by MROD assay 
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4.2 GLUTATfflONE-S-TRANSFERASE ASSAY 
In this experiment, both rat microsomal fractions and crude fractions isolated 
from cells were employed to study the effects of drugs on GST. Since my previous 
study on GA and EX showed cytoprotective effects on AFBi intoxication, this assay 
was employed to further test if GA and EX would have any effects on AFBi-induced 
toxicity. 
There are two aspects in this assay. First, the direct addition of drugs; second, 
samples were isolated from the dmg-pretreated cells and untreated cells were 
examined. These two aspects were used to see if the presence of drugs would show 
any effects on the enzyme, or the drugs would affect the enzyme level in cells. 
Rat microsomal fractions were used as the control. The specific activities of 
different GST samples were shown in Figure 4.7. The specific activity of Wistar rat 
microsomal GST was the highest, followed by L929, ECV304 and HepG2. By 












^ r - _ i 
I 0.12 - 一 丄 
~5 g 
•f 0 .08— — p t — — r f " — 
I 
1^  
§. 0.04 -—— —— 
0) 
0 ~~ ~ ~~ ~~ ~ "“^  ~~ ~ "“^  ~" ~ ~~ 
Wistar HepG2 L929 ECV 
SpecificActivitvl 0.1573 0.0762 0.1252 0.0824 
GST Samples 
Figure 4-7 Specific activity of different GST Samples 
Crude fractions of GST were prepared from rats and different cell lines: (a) HepG2, 
(b) L929 and (c) ECV304. The protein content was determined by Bradford assay. 
About 20^ig protein was pre-incubated with GSH at 37。C for 1 minute. CDNB was 
finally added to initiate the reaction. The O.D. at 340nm was measured for 1 minute 
at 5 seconds interval. The change of the absorbance was converted to the reaction 
rate. The specific activity of the sample was nmol product formed/min/mg protein. 




4.2.1 EFFECTS OF DRUGS ON GST IN CELLS 
It was found that the activity of GST was raised in direct addition of GA and 
samples from GA-cultured cells. The results were shown in Figure 4.8 - 4.10. The 
activation by direct addition of GA was about 35% for HepG2, 60% for L929 and 
170% for ECV304 at high concentration ofGA (>lOOn<M). The activation changed at 
low concentration of GA and leveled off for HepG2. No significant difference was 
found at l|iM GA with L929. The activation varied according to the concentration of 
GA when its concentration reached l^iM. Similar results were obtained with 
ECV304. The activation was not observed until the concentration of GA exceeded 
l^iM. 
The activatory effects ofGA in culture were higher than that of direct addition 
of GA. They were 150% for HepG2, 160% for L929 and 230% for ECV304. The 
effects changed with the concentration of GA. The activation was also observed at 
low concentration of GA (lpiM). 
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Figure 4-8 Effects of GA on HepG2 GST Activity 
Crude fractions ofGST were prepared from (I) HepG2 (Figure 4.8 and Figure 4.11), 
(II) L929 (Figure 4.9 and Figure 4.12) and (IE) ECV304 (Figure 4.10 and Figure 
4.13) cultured in standard medium and drug-containing medium: (a) GA and (b) EX, 
respectively. The activity ofGST from cultured HepG2 was measured in the presence 
of.(a) GA and (b) EX. The activity was compared with the control in which no GA or 
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Figure 4-9 Effects of GA on L929 GST Assay 
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Figure 4-10 Effects of GA on ECV304 GST Activity 
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The activity ofGST from cells were inhibited by EX. The results were shown 
in Figure 4.11 - 4.13. The inhibitory effect varied with the concentration o fEX with 
HepG2, L929 and ECV304. No inhibitory effects were found in direct addition ofEX 
at low concentration (lO^ig/mL) with L929 and ECV304. The effect was observed at 
low concentration ofEX (<lO^igAnL) with HepG2. The inhibitory effect was 60% for 
HepG2, 50% for both L929 and ECV304. 
The culture effects of EX on GST with cells were more obvious. The 
inhibitory effect was about 70% for HepG2, 50% for L929 and 75% for ECV304. 
The inhibitory effects changed with the concentration of EX and the inhibition was 
found at low concentration of EX (l^igAnL) with HepG2 and L929 only. No 
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Figure 4-11 Effects of EX on HepG2 GST Activity 
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Figure 4-12 Effects of EX on L929 GST Activity 
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4.2.2 EFFECTS OF AFBi AND DRUGS ON GST FROM THE RAT 
4.2.2.1 EFFECTS OF AFBi ON GST FROM THE RAT 
The effects of AFBi on GST was insignificant when AFBi was dissolved in 
1% DMSO (Figure 4.14). DMSO (1%) alone would not affect the assay. However, 
the effects of AFBi could not be measured when dissolved in DMSO. Thus, 
modifications were made. Enzyme was incubated with AFBi before assay. No 
significant difference was found even the incubation time was extended to 45 minutes 
(Figure4.15). 
AFBi was dissolved in methanol for the assay. The results were shown in 
Figure 4.16. The activity of GST was inhibited by both MeOH and AFBi. The 
inhibitory effects varied with the concentration used in this study. The inhibitory 
effects of AFBi were more severe than methanol. About 50% of the activity was 
inhibited at 50^iM AFBi in 5% methanol. 
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Figure 4-14 Effects of AFBi on GST in 1 % DMSO 
Crude fractions of GST were prepared from the rat. AFBi was prepared in 1% 
DMSO. The activity was compared with the control in which no AFBi was added. 
AFBi was directly incubated with enzymes and 20p.g protein was pre-incubated at 
3TC for 1 minute.lmM CDNB was finally added to initiate the reaction. 
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Figure 4-15 Incubation effects ofAFBi on GST in 1% DMSO 
Criide fractions ofGST were prepared from rat. AFBi in 1% DMSO was incubated at 
y f C for 0 minute, 10 minutes, 20 minutes and 30 minutes, respectively. The activity 
was compared with the control in which no AFBi was added. 
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Figure 4-16 Effects ofAFBi on GST in methanol 
Crude fractions of GST were prepared from rat. AFBi in methanol was incubated 
with 20^ig protein. The activity was compared with the control in which no AFBi was 
added. AFBi was directly incubated with enzymes and 20^g protein was pre-
incubated at 37°C for 1 minute.lmM CDNB was finally added to initiate the reaction. 
The O.D. at 340nm was measured for 1 minute at 5 seconds. The change of 
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4.2.2.2 EFFECTS OF DRUGS ON GST FROM THE RAT 
The effects of drugs on GST from the rat were recorded. GA and EX were 
found to inhibit GST activity and the inhibitory effects varied with the amount used. 
The direct addition ofdrugs and the incubation effects of drugs were studied. 
The activity was not affected until the concentration of GA reached lO[xM. An 
extremely low activity was recorded when the GA concentration reached lOO^iM. No 
activity was recorded at lmM GA. The inhibitory effect of GA on GST was 
independent on the exposure periods of GA. The activity was almost the same with 
all incubation periods. The results were shown in Figure 4.17. 
The GST activity was inhibited up to 75% at 50^igAnL EX. Unfortunately, the 
activity was not measurable when the EX concentrations were higher than 50fj<g/mL. 
For experiment studied on the incubation effects o fEX on samples，the reaction rate 
could not be measured. Therefore, no results were obtained. 
112 
Results ofGSTAssay 
~B~~Omin 一 冷一 15min _ • ^ • -30min 
125 j n r "  
_ i o o i r < T i ’ ~ ^ k r ^  
g „ *•〜“--•委,^ 
: t 75 i ^  
< \  
. I 50 V " 
co 里、\ 
I 25 ^ S ^ 
°^  0 . i 1 ‘ ‘~~\c 
0.30 0.01 0.10 1.00 1 0.00 1 00.0 id io . 
2 5 J — 0 0 0 
GA Concentration (uM) 
Figure 4-17 Incubation effects of GA on GST from rat 
Crude fractions of GST were prepared from the rat. The effects of (a) GA (Figure 
4.17) and (b) EX (Figure 4.18) on activity were compared with the control in which 
no GA or EX was added. GA or EX was incubated with enzymes for 0 minute, 15 
minutes and 30 minutes, respectively. 
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Chapter Five DISCUSSION 
Aflatoxins, especially AFBi, have been implicated as human carcinogens, 
although there is little information on the dietary exposure to AFBi in Hong Kong. 
Our neighboring provinces in China along the southeast coast have a high dietary 
AFBi exposure (Lau, G.S.N., 1997). Since the complete elimination of exposure to 
environmental carcinogens is not possible, chemoprotective interventions for specific 
human populations identified as particularly high risk could be possible (Roebuck, 
B.D. etal., 1991). 
Several chemoprotective agents, butylated hydroxyanisole (BHA), butylated 
hydroxytoluene (BHT), ethoxyquin psfetke，S.P. et cd., 1997) and oltipazand 
(Roebuck, B.D. et al., 1991) have been reported to significantly reduce the 
carcinogenic effects of AFBi. They are all synthetic compounds. Alternatively, 
naturally occurring substances are useful for chemoprotective studies nowadays. 
Ascorbic acid, AA (Iverson, F. et aL, 1987 and Netke，S.P. et al., 1997) and (+)-
cyanidanol-3 (Begue, J.M. et aL, 1988) were reported to have protective properties on 
animals from acute and chronic toxicity of AFBi. Those synthetic drugs and AA have 
been shown to exercise their beneficial effects by modifying the activities mainly of 
hepatic Phase I enzymes and Phase II enzymes, mostly GST, to various extents 
ONfetke, S.P. et al., 1997). (+)-Cyanidanol-3 and AA have been shown to be effective 
free radical scavengers in their hepatoprotective ability (Begue, J.M. et al, 1988 and 
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Netke, S.P. et aL, 1997). As a result, other naturally occurring substances possessed 
chemoprotective ability or antioxidative effects are ofinterest for the present study. 
Licorice plant and its major component GA were well known for their 
antiallergic and antiinflammaroty effects. In 1958, GA was first used for the 
treatment of chronic hepatitis. Distinct improvement in the liver function was tested 
(Tanaka, N. et aI., 1993). Many investigators have reported that administration ofa 
high dose of GA (80-200mg) was effective for improving the liver function in 
patients with hepatitis (Yamamura, Y. et al, 1995). Since GA is noted for the 
treatment of chronic hepatitis (Tanaka, N. et aL, 1993 and Yamamura, Y. et al., 
1997), excellent results have also been obtained in the study of liver damages, 
including acute hepatitis, liver cirrhosis (Yamamura, Y. et al., 1995) and carbon-
tetrachloride induced liver damages (Kiso, Y. et aL, 1984 and Yamamura, Y. et aL, 
1997). Other studies also revealed that anti-oxidative action of GA played an 
important part in the antihepatotoxic activity against carbon-tetrachloride induced live 
damages (Kiso, Y. et al., 1984). Also GA had significant restorative and protective 
effects on GST activity and GSH contents in the liver (Yamamura, Y. et a/.’ 1995). 
Scientists believed that the antioxidative ability and the restorative of GST activity 
contributed to GA antihepatotoxic ability. Moreover, GA was widely used in the 
commercial market as sweetener, drugs, beverages, chewing-gums and toothpaste 
(Stormer, F.C., Reistad, R. and Alexander, J., 1993). Thus, it is of interest to study 
GA for their protective ability against AFBi intoxication. 
Since the objectives of my research were to study chemoprotective agents 
against AFBi intoxication, the study of cytotoxicity of AFBi was included. Different 
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cells and assay methods were used to study the cytotoxicity of AFBi. Previous studies 
suggested that the primary cultures were phenotypically unstable, losing many of 
their differentiated functions, including P450s activities in 48 hours to 72 hours 
(Shinha, S.，Hockin, L.J. and Neal, G.E., 1987 and Doosrdar, H. et al., 1993) due to 
the reduction of P450 levels in cultured hepatocytes (Chih, J.J.，Lin, T. and Devlin, 
T.M., 1983). Only 25% ofthe P450 activity remained after 24 hours incubation was 
reported (Dawson, J.R., Adams, D.J. and Wolf, C.R., 1985). Therefore, the 
hepatocytes required enriched medium to maintain cytochrome P450 levels so as to 
ensure the metabolic capability of hepatocytes to metabolize xenobiotics (Decad, 
G.M., Hsieh, D.P.H. and Byard, J.L., 1977). Furthermore primary hepatocytes are 
non-proliferating and have a limited life span in culture. The HepG2 human hepatoma 
cell line was an immortal cell culture system (Doosrdar, H. etal., 1993). HepG2 cells 
retained many of the morphological and biochemical characteristics of normal 
hepatocytes (Thabrew, M. I , Hughes, R.D. and Mcfarlane, I.G., 1997). Also these 
cells carried out both P450 and conjugation reactions and activated xenobiotics to 
cytotoxic and/or mutagenic metabolites (Sassa, S. et al., 1987; Grant, M.H. and 
Duthie, S.J., 1988 and Doosrdar, H. et aL’ 1993). 
Apart from the liver damages，enlarged spleen was another observation 
commonly reported in AFBi intoxication. It was considered as the preliminary 
evidence for leukemia or lymphoma, another syndrome mostly observed in AFBi 
intoxication. Therefore spleen was also considered as a sensitive organ to AFBi 
intoxication. It was thought to be an alternative model for studying AFBi cytotoxicity 
(Roebuck, B.D. etal., 1991). 
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Different assay methods were employed to determine the viability of 
splenocytes. Different results were obtained. The LC50 value of AFBi for splenocytes 
w2ts about 50^iM by trypan blue exclusion staining, but no LC50 value was recorded 
using MTT assay. The viability of splenocytes was higher by the MTT assay when 
more AFBi was incubated with the cell. The difference was further validated by 
HepG2 model. Mitochondria were also studied to see if AFBi affected the MTT 
assay. Similar finding was obtained with HepG2 model but the level of activation was 
less than splenocytes. In mitochondria study, the amount of formazan measured was 
increased by AFBi. Hence the activity of mitochondria affected the MTT assay in the 
presence ofAFBi. This was the first report on the effects of AFBi on mitochondria. 
The activation mechanism was beyond this research objective. However, the 
interactions are worth further studied and more works should be concentrated on the 
effects of AFBi on mitochondria. 
5.1 CYTOTOXICITY OF AFB 1 
It was no doubt that AFBi caused cell death (Denning, D.W., 1987). 
Investigators suggested that toxic metabolites inhibited the DNA and RNA synthesis 
resulting in cell death. Results showed in the previous chapters that AFBi was toxic 
to both freshly isolated splenocytes and cell lines. The level of cytotoxicity was 
expressed in terms ofLC50. The smaller LC50 value indicated that it was more toxic. 
The LC50 ofAFBi after 24 hours intoxication was 50^iM for splenocytes. The LC50 of 




for ECV304. The LC50 ofHepG2 was the highest among the three cell lines studied. 
The order of sensitivity to AFBi cytotoxicity was splenocytes > ECV304 > L929 > 
HepG2. Therefore, primary cells were more sensitive to AFBi intoxication. Cancer 
cells were least sensitive to AFBi cytotoxicity. 
Previous studies reported that the target organ of the acute and chronic effects 
of AFBi was the liver. Thus, liver cell line was also used in the study. The results 
were compared with other cell lines, mouse hepatoma, Hepa-1 and rat hepatoma, 
HTC. The LC50 for Hepa-1 and HTC were 20^iM and l^iM, respectively. Thus, rat 
hepatoma was believed to be exceptionally sensitive to AFBi. Hepa-1 was showed to 
be about 20 times more susceptible than HTC, and 100 times than HepG2. So HepG2 
was least susceptible than Hepa-1 and HTC. Hence, rat was thought to be more 
susceptible to AFBi intoxication, followed by mouse and human. The metabolic 
mechanism of AFBi in Hepa-1, HTC and HepG2 were believed to be different. 
HepG2 was particularly suitable for chemoprotection study. Also, the possible 
species differences in responses were avoided by the use of cells from man rather 
than animals (Karenlampi, S.0.,1987). 
5.2 CYTOTOXICITY OF EX , G A AND A A 
Previous studies of GA were on its protective effects against liver damages 
(Tanaka, N. et aL, 1993; Yamamura, Y. et al.’ 1995; Wang, Z. et cd., 1996 and 
Yamamura, Y. et al, 1997). Other toxic effects of GA were also reported (Stormer, 
F.C., Reistad, R. and Alexander, J., 1993). This was the first report on the toxicity of 
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GA on cells. GA was comparatively non-toxic to HepG2 and L929. Mild toxicity was 
found for ECV304, but the adverse effects were independent on the incubation 
period. 
On the other hand, significant reduction in cell viability was observed in all 
cell lines incubated with different concentrations of EX. Severe cell death was 
observed from L929 and HepG2 at lmg/mL and 500^ig/mL EX, respectively. The 
viability ofHepG2 was <20% and the viability of L929 <50%. Similar results were 
obtained in ECV304. Therefore, EX was toxic to cells only at high concentration. 
HepG2 was less sensitive to EX while L929 and ECV304 were comparatively more 
sensitive. 
This implied that the toxic effects might be due to other interacting 
components in licorice plants. The components existed in very low concentration 
while large amount ofthese compounds exerted toxicity. At the same time, lmM AA 
was found toxic to all cell lines. It was different from the previous studies on animals 
at high doses in that no mortality was found with an intake of 300mg AA QSfetke，S.P. 
et al., 1997). 
• Therefore, L929 and ECV304 were more sensitive than HepG2 to tested 
chemicals. The effects of GA, AA and EX were compared. GA was relatively non-
toxic to all cells studied. Cell death was monitored only at extremely high 
concentration of EX and AA. Consequently, a wide range of concentrations of 
chemical could be used. The concentrations employed in the chemoprotective assay 
showed no adverse effects on cells. Thus, the concentrations of EX used was lower 
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than 250 l^gy'mL and the concentrations of GA and AA used did not exceed 250[M. 
These concentrations had no observed adverse effects on cells. 
5.3 CHEMOPROTECTION OF GA AND E X ON AFBi CYTOTOXICITY 
The present investigations were designed primarily to determine whether an 
increase in the amount of drugs and an increase in the incubation time of drugs 
protected cells from AFBi intoxication. The presence of GA, EX or AA partially 
revived cell viability. 
The cell viability had no significant difference between low drug 
concentration and high drug concentrations. This indicated that the cell viability was 
not improved by the increase of concentration ofGA, EX or AA. 
In the direct addition effects of drugs on HepG2, the revival of cell viability 
by AA was the highest comparing with EX and GA, while GA and EX showed 
similar protection for cells. The protective effects of drugs were more obvious in 
sever AFBi intoxication. No revival of cell viability was obtained with mild AFBi 
intoxication. This indicated that the chemoprotection of AA, GA and EX were more 
noticeable at high concentration of AFBi. In L929, AA showed the protection for 
cells in both mild and severe AFBi intoxication. The revival of cell viability was 
about 30% in sever AFBi intoxication. GA and EX exerted their protective ability 
only at high concentration ofAFBi. Similar protection level by AA, GA and EX was 
found for ECV304 cells. The greatest protective effect was obtained with mild AFBi 
intoxication that was similar to the results obtained using L929. 
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In sever AFBi intoxication, similar responses were found with L929 and 
HepG2 cells. About 10-20% ofthe HepG2 viability was revived. About 30% of cell 
viability was revived in ECV304. This indicated that ECV304 was more sensitive to 
these drugs. From the cytotoxicity studies, ECV304 was also found to be the most 
sensitive samples to drugs and AFBi. In contrast, HepG2 and L929 seemed to be 
sensitive cell lines. Therefore they were good models for experiments. 
On the other hand, different treatments of cells showed that the viability was 
improved by the increase of exposure period of time to drugs. Short-term 
pretreatment of cells with drugs enhanced the protective effects ofdrugs. The pattern 
ofthe protection was alike with the direct addition effects of drugs. Different results 
were achieved from cells cultured in drugs-containing medium. This indicated that 
the effects ofdrugs needed time to exhibit the protective ability. 
Complete protection against AFBi cytotoxicity was found in HepG2 cultured 
in EX-containing medium. Different findings were obtained with ECV304. Cells 
cultured in GA-containing medium showed strongest resistance to AFBi intoxication, 
followed by cultured in EX and AA. The protection of GA to AFBi intoxication was 
about 60% with severe AFBi intoxication. 
Hence, the protection of cells by drugs against AFBi intoxication varied 
among cell lines. The action of chemoprotection was time-dependent but not dose-
dependent in all cell types. So, in order to achieve better viability, the prolonged 
exposure ofcells to minimal concentrations of GA, EX and AA should be employed. 
The reasons for the variation in responses were not clear from the previous studies. 
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5 4 EFFECTS OF GA AND E X ON ENZYMES INVOLVED E^ AFBi 
METABOLISM 
The metabolism of AFBi was well established. There was much evidence 
indicating that AFBi required metabolic activation to exert its biological and 
biochemical toxicity. Epoxidation was believed to be the most important AFBi 
metabolic pathway involved and was catalyzed by P450 enzymes. Different reports 
suggested that there were several isoenzymes responsible for the metabolic activation. 
CYPlA, CYP2A and CYP3A were probably involved in the epoxidation (Hayes, I D . 
et-al., 1991; Eaton, D.L. and Gallagher, E.P., 1994; Mclean, M. and Dutton, M.F., 
1995 and Guengerich, F.P. etal., 1998). 
Other scientists also suggested that CYPlA possessed the highest specific 
activity in epoxidation. CYPlA had high affinity for AFBi at low concentration of 
AFBi, where as CYP3A was capable of AFBi oxidation only at high substrate 
concentrations (Eaton, D.L. and Gallagher, E.P., 1994). Good correlation between the 
level of CYP3A and the rates of metabolic activation of AFBi was reported 
(Shimada, T. and Guengerich, F.P., 1989). Hayes believed that CYP3A remained one 
ofthe better possibilities in AFBi bioactivation because of its abundant existence in 
human (Hayes, J.D. et aL, 1991 and Ueng, Y.F. et al., 1997). The effects of 
chemoprotective agents on CYPlA was studied in my project. 
Previous studies reported that CYPlA family included two genes, CYP1A1 
and CYP lA2, rat CYP1A1 preferentially metabolized ER but not MR. In contrast, it 
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was found that CYPlA2 readily metabolized MR while metabolizing ER at a much 
lower rate O^erurkar, P.V. et al., 1993). As a result, the effects of GA and EX on 
CYPlA could be measured by the EROD and MROD assay. 
Following the formation of the AFBi-epoxide, the major detoxification 
pathway was by conjugation with glutathione to form AFBi-glutathione (AFBi-GSH) 
(Degen, G.H. and Neumann, H., 1978; Gopalan, P., Jensen, D.E. and Lotlikar, P.D, 
1992; Buetler, T.M., Slone, D. and Eaton, D.L., 1992 and Johnson, W.W. et al., 
1997). There were other minor detoxification pathways: the reaction of other phase II 
enzymes, UDP-glucuronosyltransferase (UGT), the reaction by epoxide hydrolase 
and the spontaneous hydrolysis of epoxide (Hayes, J.D. et al., 1991). Since the 
enzymatic reaction catalyzed by epoxide hydrolase was as low as the spontaneous 
hydrolysis of epoxide, little evidence supported the role of epoxide hydrolase in the 
detoxication of AFBi (Johnson, W.W. et al., 1997). These pathways might not be 
involved in removing those toxic epoxides (Hayes, J.D. et al., 1991; Eaton, D.L. and 
Gallagher, E.P., 1994; Mclean, M. and Dutton, M.F.，1995; Guengerich, F.P. et aL, 
1998). 
There were two principal approaches for my research on the chemoprotective 
agents against AFBi toxicity. It was to test the ability of the chemoprotective agents 
to affect the metabolic activation by P450s, and the detoxification process by GST. 
The major findings of this study were that licorice plant and its major component, 
G ^ showed protection against cytotoxicity of AFBi. The protection mechanism of 
many hepatoprotective agents was not known. The effects of these chemicals on the 
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enzymes involved in the metabolism might provide information on the protection 
mechanism. 
The studies failed to monitor the activity of P450 enzymes from cells. Thus, 
oniy the enzymes isolated from Wistar Rat livers were studied. The activity of rat 
microsomal fractions was different from that of the enzymes prepared from cells. 
Rats and cells were used as models sfor studying the effects of chemoprotective 
agents. 
In the study ofeffects of AFBi on P450s, previous studies suggested CYPlA 
had high specific activity on the epoxidation of AFBi. The inhibition of P450 by 
AFBi may be due to the toxic effects of AFBi on the enzyme. The inhibition was not 
sever (<20%). P450 still exerted their major functions under these stresses. 
The activation of P450 by GA was time-dependent and dose-dependent in 
EROD assay. That's to say, increasing the concentration of GA and increasing the 
period of incubation time activated CYP1A1. In MROD assay, the activity was not 
significantly activated by series of GA concentrations and the incubation periods. The 
activation of enzyme activity was more obvious in EROD than MROD. The results 
agreed with the previous report on the induction ofP450 in mice which indicated that 
CYP1A1 was highly inducible while CYPlA2 was only minimally inducible 
O^Ierurkar, P.V. etaL, 1993). 
Compared the effects of EX and GA on CYPlA, opposite results were 
obtained in the EROD assay. The activity was inhibited by EX. Good correlation was 
found between the inhibitory effect of enzyme activity and the concentration of EX 
and the incubation period. Similar findings were also obtained by the MROD assay, 
125 
Discussion 
„ « » = » « = « = = „ _ „ „ _ _ _ _ « _ _ « « _ _ « _ » _ » « « — = « ~ « = ~ — » ~ ~ = » ~ ~ ~ ~ — ~ ~ — ~ ~ = = = — = =  
the previous findings on the cytotoxic effects ofEX described in the previous chapter. 
However, licorice extract and GA were not able to induce total CYP contents or 
different CYP isoforms such as CYP3A. The difference may be due to the species 
difference and the toxicity ofAFBi on the specific isoform. Also, the effect o fEX is 
different from its individual components. A recent report also suggested that an 
increase of different CYPs by licorice extract were observed. For example, CYP3A 
was detected by Westem blot analysis (Paolini, M. et al., 1998). It seems the major 
enzyme is inducible. These results suggested that the induction of P450 by the 
prolonged intake of high licorice or GA might result in accelerated metabolism of 
drugs with important implications for their disposition (Paolini, M. et al‘, 1998). 
These results suggested that GA activated the metabolism of AFBi to produce toxic 
metabolites. The experimental findings revealed that GA did exert protection against 
AFBi cytotoxicity. Thus, the protective property of licorice plant and GA was not 
mainly due to the inhibitory effects on the formation of toxic metabolites. 
Apart from P450s, GST was the major enzyme responsible for the 
detoxification of AFBi. There were five classes of GST, but no evidence showed 
which specific isozyme of GST is responsible for the removal of AFBi-epxoide. 
Therefore, only the crude fraction of GST was examined in order to get a global idea 
of effects of GA on GST. Amongst the four samples, Wistar rat GST showed the 
highest specific activity, followed by L929, whereas HepG2 and ECV304 were alike 
and the specific activity were the lowest. Since the present investigation and previous 
studies did not provide the specific activity of P450 among these four samples in 
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metabolizing AFBi, it was difficult to compare the susceptibility of these samples in 
AFBi intoxication based on the specific activity ofGST. 
GST samples were treated with EX and GA in two ways: the direct addition 
of drugs to assay mixture and the culture effect of drugs to cells. These two aspects 
revealed effects o fEX or GA on the enzyme. The rationale was to see ifthe presence 
o fEX or GA had any effect on the enzymatic reaction, whereas the rationale of the 
latter was to see i fEX or GA had any inducible effect on cells. 
In all cell lines, the specific activity of GST were increased in the direct 
addition ofGA. About 30% of the activity was activated in HepG2 samples. More 
than 60% was increased in L929 and ECV304 samples. Good correlation between the 
enzymatic activation and the concentration of GA was obtained with L929 and 
ECV304 samples. The activation was likely to be enhanced if more GA was added to 
these samples. However, in HepG2 assay, the activation leveled off at high 
concentration of GA. No more activation was detected by adding more GA to the 
HepG2 samples. Moreover, the activity ofL929 and ECV304 was found double that 
of HepG2. Thus, they were more sensitive to activation by GA. Therefore, the 
activation process by GA on GST activity varied among cell lines. Since the removal 
of AFBi was enhanced in cells, it was believed to be the reason for reduction of 
cytotoxicity ofAFBi in cells. Since the effects of GA in bioactivation of AFBi were 
not observable, it was difficult to describe the effects of GA on AFBi intoxication to 
cells. 
In contrast, the activity of GST in the rat sample was inhibited by GA. It was 
in good correlation between the concentration of GA and the inhibition. A recent 
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Study reported that GA activated glucurronidation. It was another phase II reaction 
that did not dominate in AFBi detoxification. This could activate the detoxification of 
xenobiotics in rat liver by other phase II enzymatic systems (Moon, A. and Kim, 
S.H., 1996). The results indicated different effects of GA on GST and UGT 
responsible for gluronidation in rat. Besides, the activity of GST in cells incubating 
with drugs was increased in all cell lines. More works were needed to study the 
activation mechanism involved. 
Opposite results were obtained on the effects of EX on GST. The activity of 
GST was inhibited by EX in cells and rats. The activity of GST decreased with the 
increase ofthe concentration ofEX in assays by the direct addition o fEX to the assay 
mixture and the effects of EX on cells cultured in EX-enriched medium. This 
indicated that there were some unknown factors other than GA in the EX that 
inhibited the activity of GST. Prolonged exposure to these compounds further 
inhibited the activity of GST. The biochemical properties of these components 
needed further investigation. 
In conclusion, the protective properties o fEX were not due to GA alone. The 
presence of other materials in licorice plant helped protect cells from AFBi 
intoxication. Since there were many other components and factors in the extract, 
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